Home › Uterine Fibroids › NCT05386615
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
RecruitingObservational study
Who can join
Ages 18 to 50 · Women
Full eligibility criteria
Inclusion Criteria: - - Eligibility is as per the symptomatic fibroids device indication. - All registry-consented patients following the treatment of their fibroid(s) with the Exablate system. Exclusion Criteria: -
About the study
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
What is being tested
- Body System - Functional (device)
Sponsor: InSightec · Participants: 200 · Started: Feb 16, 2016
Contact the study team
- Nadir Alikacem · Phone: +12146302000
Official record on ClinicalTrials.gov — NCT05386615
Locations in the U.S.
| California | UCLA, Los Angeles Stanford University, Stanford |
| Minnesota | Mayo Clinic, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.